Skip to content
TrialMatch
Sign up
Recruiting

The Sunnybrook Type 2 Diabetes Study

Create a profile to match View the full record on ClinicalTrials.gov

About this study

The Sunnybrook Type 2 Diabetes Study (S2DS) is a prospective observational study of people with prediabetes or Type 2 Diabetes Mellitus (T2DM), that aims to understand the aetiologies, manifestations, and clinical consequences of mood and cognitive complications. The study recruits from the services at Sunnybrook Health Sciences Centre and from the neighbouring University Health Network Toronto Rehabilitation Institute Cardiac Rehabilitation Program.

Condition
Type 2 Diabetes, PreDiabetes
Tested
Diabetes Exercise and Healthy Lifestyle Program, Outpatient care
Sponsor
Sunnybrook Health Sciences Centre

Who can join

Age
18 years and older
Sex
All sexes
Healthy volunteers
Not accepted

Inclusion 5

  • Minimum age: 18 years
  • Study condition: Type 2 Diabetes, PreDiabetes
  • Have at least one of the following: high HbA1c, impaired fasting glucose (IFG), impaired glucose tolerance (IGT), but not yet diagnosed with Type 2 diabetes or have a diagnosis of Type 2 diabetes.
  • Be able to communicate in English
  • Be 18 years of age or older

Exclusion 15

  • Pregnancy
  • Inability to give informed consent
  • Current cancer diagnosis
  • Have a prior diagnosis of bipolar disorder or schizophrenia.
  • Have a prior diagnosis of a neurological and/or neurodegenerative disorder.
  • Have a current substance use disorder or a previous substance use disorder diagnosed within the last 5 years (excluding nicotine)
  • Poor score on the Mini Mental State Examination (MMSE)
  • Contraindications to SHSC's MRI safety protocol.
  • Participants that do not meet the inclusion/exclusion criteria of the main study.
  • Use of medical equipment that would interfere with the placement of the CVR mask.
  • Significant pulmonary disease (e.g. asthma, pulmonary fibrosis, emphysema, chronic obstructive pulmonary disease, pulmonary vascular disease, pleural disorders, pneumonia)
  • Participants that do not meet the criteria for the MRI sub-study.
  • Participants that have a medical device that would interfere with placement of portable sleep monitor equipment i.e. Participant requires O2 therapy and uses nasal prongs
  • Participants that have a condition that may compromise accuracy of the HSAT results i.e. moderate-severe pulmonary disease or congestive heart failure
  • Participants that do not meet the inclusion/exclusion criteria of the main study

Where

1 site, 1 recruiting

Sunnybrook Research Institute

Toronto, Ontario, Canada

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.